Wesana Health Holdings Inc.
WESAX
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -85.01% | -41.20% | -77.19% | -77.64% | 133.48% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -85.01% | -41.20% | -77.19% | -77.64% | 133.48% |
| Operating Income | 85.01% | 41.20% | 77.19% | 77.64% | -133.48% |
| Income Before Tax | 96.98% | 27.79% | 48.19% | 87.84% | -286.06% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 96.98% | 27.79% | 48.19% | 87.84% | -286.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -156.77% | 457.66% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -110.91% | 71.33% | 67.64% | 44.76% | 53.14% |
| EBIT | 85.01% | 41.20% | 77.19% | 77.64% | -133.48% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -110.42% | 71.28% | 67.91% | 44.77% | 52.38% |
| Normalized Basic EPS | 78.79% | 39.58% | 72.60% | 129.38% | -134.74% |
| EPS Diluted | -110.42% | 71.28% | 67.91% | 44.77% | 52.38% |
| Normalized Diluted EPS | 78.79% | 39.58% | 72.60% | 129.38% | -134.74% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.21% | 0.27% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.21% | 0.27% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
